Subtopic Deep Dive

← Neutrophil, Myeloperoxidase and Oxidative Mechanisms

NADPH Oxidase in Neutrophil ROS Production
Research Guide

What is NADPH Oxidase in Neutrophil ROS Production?

NADPH oxidase (NOX2) is the multi-subunit enzyme complex in neutrophils that assembles during respiratory burst to generate superoxide anion as the primary reactive oxygen species (ROS) for microbial killing.

NOX2 consists of membrane-bound gp91phox and p22phox with cytosolic p47phox, p67phox, p40phox, and Rac GTPase that translocate upon activation. Defects in NOX2 cause chronic granulomatous disease (CGD) with recurrent infections. Over 20 papers detail its structure and neutrophil-specific function, including Panday et al. (2014, 900 citations) and Sumimoto (2008, 692 citations).

Curated Papers

Key Challenges

Why It Matters

NOX2-driven ROS production in neutrophils defends against pathogens but contributes to tissue damage in inflammatory diseases like rheumatoid arthritis and cardiovascular disorders (Forrester et al., 2018, 1892 citations). Dysregulated NADPH oxidase activity links to hypertension and atherosclerosis via endothelial dysfunction (Lassègue et al., 2012, 750 citations; Paravicini and Touyz, 2008, 692 citations). Therapeutic targeting of NOX2 assembly modulates immunity, as seen in CGD gene therapy trials and apocynin studies, though Heumüller et al. (2007, 726 citations) showed apocynin acts as an antioxidant, not direct inhibitor.

Key Research Challenges

NOX2 Assembly Regulation

Precise spatiotemporal control of cytosolic subunit translocation to phagosomal membrane remains unclear. Panday et al. (2014) overview structural requirements, but dynamic phosphorylation events need better models. Sumimoto (2008) details evolution but lacks neutrophil-specific kinetics.

Therapeutic Inhibition Specificity

Selective NOX2 inhibitors avoid off-target effects on other Nox isoforms. Heumüller et al. (2007) debunked apocynin as NADPH oxidase inhibitor. Lassègue et al. (2012) highlight cardiovascular Nox isoform overlaps complicating neutrophil-targeted drugs.

ROS Quantification in Neutrophils

Distinguishing NOX2-derived superoxide from mitochondrial ROS challenges live-cell assays. Dunn et al. (2015, 1149 citations) discuss mitochondria-ROS nexus. Brieger et al. (2012, 1057 citations) note assay artifacts in health-disease transitions.

Essential Papers

Reactive Oxygen Species in Metabolic and Inflammatory Signaling

Steven J. Forrester, Daniel S. Kikuchi, Marina S. Hernandes et al. · 2018 · Circulation Research · 1.9K citations

Reactive oxygen species (ROS) are well known for their role in mediating both physiological and pathophysiological signal transduction. Enzymes and subcellular compartments that typically produce R...

Reactive oxygen species and mitochondria: A nexus of cellular homeostasis

Joe Dan Dunn, Luis Álvarez, Xuezhi Zhang et al. · 2015 · Redox Biology · 1.1K citations

Reactive oxygen species (ROS) are integral components of multiple cellular pathways even though excessive or inappropriately localized ROS damage cells. ROS function as anti-microbial effector mole...

Reactive oxygen species: from health to disease

Katharine Brieger, Stefania Schiavone, Francis J. Miller et al. · 2012 · Swiss Medical Weekly · 1.1K citations

Upon reaction with electrons, oxygen is transformed into reactive oxygen species (ROS). It has long been known that ROS can destroy bacteria and destroy human cells, but research in recent decades ...

TNF and ROS Crosstalk in Inflammation

Heiko Blaser, Catherine Dostert, Tak W. Mak et al. · 2016 · Trends in Cell Biology · 951 citations

NADPH oxidases: an overview from structure to innate immunity-associated pathologies

Arvind Panday, Malaya K. Sahoo, Diana Osorio et al. · 2014 · Cellular and Molecular Immunology · 900 citations

Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System

Bernard Lassègue, Alejandra San Martín, Kathy K. Griendling · 2012 · Circulation Research · 750 citations

atherosclerosis, hypertension, cardiac hypertrophy and remodeling, angiogenesis and collateral formation, stroke, and heart failure. In this review, we discuss in detail the biochemistry of Nox enz...

Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant

Sabine Heumüller, Sven Wind, Eduardo Barbosa‐Sicard et al. · 2007 · Hypertension · 726 citations

A large body of literature suggest that vascular reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases are important sources of reactive oxygen species. Many studies, however, relied...

Reading Guide

Foundational Papers

Start with Panday et al. (2014, 900 citations) for NOX2 overview from structure to CGD pathologies, then Sumimoto (2008, 692 citations) for regulation mechanisms, and Heumüller et al. (2007, 726 citations) to understand inhibitor pitfalls.

Recent Advances

Forrester et al. (2018, 1892 citations) on ROS signaling; Dunn et al. (2015, 1149 citations) on mitochondria interplay; Blaser et al. (2016, 951 citations) on TNF-ROS crosstalk in inflammation.

Core Methods

Neutrophil isolation for DHR assays; flavoprotein probes for activity; cytochrome b558 immunoblotting; Rac GTPase pulldowns; live imaging of p47phox translocation (Panday et al., 2014; Sumimoto, 2008).

How PapersFlow Helps You Research NADPH Oxidase in Neutrophil ROS Production

Discover & Search

Research Agent uses searchPapers('NADPH oxidase neutrophil ROS') to retrieve 50+ papers like Panday et al. (2014), then citationGraph reveals Forrester et al. (2018, 1892 citations) as hub connecting inflammation to ROS signaling. findSimilarPapers on Sumimoto (2008) uncovers isoform-specific evolution papers; exaSearch drills into neutrophil CGD cases.

Analyze & Verify

Analysis Agent employs readPaperContent on Heumüller et al. (2007) to extract apocynin data, then verifyResponse with CoVe cross-checks against Lassègue et al. (2012) for inhibitor validation. runPythonAnalysis simulates ROS production kinetics from Dunn et al. (2015) data using NumPy/pandas, with GRADE scoring evidence strength for NOX2 vs. mitochondrial sources.

Synthesize & Write

Synthesis Agent detects gaps in NOX2 therapeutic specificity between Panday et al. (2014) and recent works, flagging contradictions on apocynin. Writing Agent uses latexEditText for neutrophil assembly diagrams, latexSyncCitations integrates 20 papers, and latexCompile generates publication-ready reviews; exportMermaid visualizes NOX2 activation cascades.

Use Cases

"Model NOX2 superoxide production rates from neutrophil assays in Panday 2014"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas plot kinetics) → matplotlib graph of burst curves

"Write LaTeX review on NOX2 defects in CGD with citations"

Research Agent → citationGraph → Synthesis Agent → gap detection → Writing Agent → latexSyncCitations + latexCompile → PDF review

"Find code for NADPH oxidase simulation in neutrophil papers"

Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified ROS model scripts

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'NOX2 neutrophil burst', structures report with GRADE-graded sections on assembly (Panday 2014) and pathology (Forrester 2018). DeepScan applies 7-step CoVe to verify apocynin claims (Heumüller 2007) against isoform data. Theorizer generates hypotheses on NOX2-mitochondria crosstalk from Dunn et al. (2015).

Try Doxa for NADPH Oxidase in Neutrophil ROS Production Research

Frequently Asked Questions

What defines NADPH oxidase in neutrophil ROS production?

NOX2 complex generates superoxide in neutrophil phagosomes via gp91phox flavocytochrome and p47phox/p67phox/Rac assembly during respiratory burst (Panday et al., 2014).

What are key methods to study NOX2 function?

DHR123 flow cytometry measures ROS in neutrophils; siRNA knockdown targets subunits; inhibitors like DPI probe activity, though apocynin is antioxidant only (Heumüller et al., 2007).

What are seminal papers on this topic?

Panday et al. (2014, 900 citations) overviews structure-to-pathology; Sumimoto (2008, 692 citations) details regulation; Forrester et al. (2018, 1892 citations) links to inflammation.

What open problems exist in NOX2 research?

Developing isoform-selective inhibitors; quantifying compartmental ROS fluxes; modeling assembly dynamics in CGD variants (Lassègue et al., 2012; Dunn et al., 2015).